118 related articles for article (PubMed ID: 30881346)
1. Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment.
Nomoto H; Kameda H; Nakamura A; Tsuchida K; Nagai S; Atsumi T; Miyoshi H
Front Endocrinol (Lausanne); 2019; 10():131. PubMed ID: 30881346
[TBL] [Abstract][Full Text] [Related]
2. Challenges in the functional diagnosis of thyroid nodules before surgery for TSH-producing pituitary adenoma.
Tatsushima K; Takeshita A; Fukata S; Fukuhara N; Yamaguchi-Okada M; Nishioka H; Takeuchi Y
Endocrinol Diabetes Metab Case Rep; 2021 Apr; 2021():. PubMed ID: 33929339
[TBL] [Abstract][Full Text] [Related]
3. Real-time elastography in autonomously functioning thyroid nodules: relationship with TSH levels, scintigraphy, and ultrasound patterns.
Trimboli P; Paone G; Zatelli MC; Ceriani L; Giovanella L
Endocrine; 2017 Dec; 58(3):488-494. PubMed ID: 28285385
[TBL] [Abstract][Full Text] [Related]
4. A pregnant woman with an autonomously functioning thyroid nodule: a case report.
Notsu M; Yamauchi M; Sugimoto T; Kanasaki K
Gynecol Endocrinol; 2020 Dec; 36(12):1140-1143. PubMed ID: 32954874
[TBL] [Abstract][Full Text] [Related]
5. Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly.
Yamamoto R; Robert Shima K; Igawa H; Kaikoi Y; Sasagawa Y; Hayashi Y; Inoshita N; Fukuoka H; Takahashi Y; Takamura T
Endocr J; 2018 Oct; 65(10):1061-1067. PubMed ID: 30078825
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Acromegaly in which a Pituitary Gland Tumor was Reduced Significantly by Administering Octreotide Long Acting Release (LAR) and Could Be Removed Surgically].
Arao T; Okada Y; Uemura F; Nishizawa S; Tanaka Y
J UOEH; 2017; 39(3):241-245. PubMed ID: 28904276
[TBL] [Abstract][Full Text] [Related]
7. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
9. Poorly-controlled acromegaly accompanied by subclinical adrenal Cushing's syndrome after surgery for multiple endocrine tumors.
Ishikawa M; Kato M; Sasaki H; Morii T; Fujita H; Kakei M; Narita T; Yamada Y
Intern Med; 2015; 54(6):617-20. PubMed ID: 25786452
[TBL] [Abstract][Full Text] [Related]
10. Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland.
Kasagi K; Shimatsu A; Miyamoto S; Misaki T; Sakahara H; Konishi J
Thyroid; 1999 Aug; 9(8):791-6. PubMed ID: 10482372
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
12. Autonomously hyperfunctioning cystic nodule harbouring thyroid carcinoma - Case report and literature review.
Lima MJ; Soares V; Koch P; Silva A; Taveira-Gomes A
Int J Surg Case Rep; 2018; 42():287-289. PubMed ID: 29331885
[TBL] [Abstract][Full Text] [Related]
13. Transient thyrotoxicosis in a patient with a functioning nodule; a possible occurrence of silent thyroiditis.
Kasagi K; Matsumoto S; Takeuchi R; Misaki T; Konishi J
Ann Nucl Med; 1992 May; 6(2):117-20. PubMed ID: 1622726
[TBL] [Abstract][Full Text] [Related]
14. Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions.
Giovanella L; D'Aurizio F; Campenni' A; Ruggeri RM; Baldari S; Verburg FA; Trimboli P; Ceriani L
Endocrine; 2016 Dec; 54(3):757-761. PubMed ID: 27628737
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.
Vance ML; Harris AG
Arch Intern Med; 1991 Aug; 151(8):1573-8. PubMed ID: 1872661
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
Öberg K; Lamberts SW
Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
Colao A; Ferone D; Marzullo P; Cappabianca P; Cirillo S; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2001 Jun; 86(6):2779-86. PubMed ID: 11397887
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma mimicking an autonomous functioning nodule.
Rivas I; Gutiérrez C; Vendrell J; Razkin S; Richart C
J Endocrinol Invest; 1995 Mar; 18(3):224-7. PubMed ID: 7615909
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group.
Giusti M; Gussoni G; Cuttica CM; Giordano G
J Clin Endocrinol Metab; 1996 Jun; 81(6):2089-97. PubMed ID: 8964833
[TBL] [Abstract][Full Text] [Related]
20. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules.
Hamburger JI; Taylor CI
Ann Intern Med; 1979 Sep; 91(3):406-9. PubMed ID: 475169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
